BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 19097175)

  • 1. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation.
    Romito LM; Contarino MF; Vanacore N; Bentivoglio AR; Scerrati M; Albanese A
    Mov Disord; 2009 Mar; 24(4):557-63. PubMed ID: 19097175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P; Batir A; Van Blercom N; Chabardes S; Fraix V; Ardouin C; Koudsie A; Limousin PD; Benazzouz A; LeBas JF; Benabid AL; Pollak P
    N Engl J Med; 2003 Nov; 349(20):1925-34. PubMed ID: 14614167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.
    Østergaard K; Aa Sunde N
    Mov Disord; 2006 May; 21(5):624-31. PubMed ID: 16283616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation.
    Anheim M; Batir A; Fraix V; Silem M; Chabardès S; Seigneuret E; Krack P; Benabid AL; Pollak P
    Arch Neurol; 2008 May; 65(5):612-6. PubMed ID: 18474736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Critical review of the subthalamic stimulation in Parkinson's disease].
    Guridi J; Rodríguez-Oroz MC; Clavero P; Manrique M
    Neurocirugia (Astur); 2009 Dec; 20(6):521-32. PubMed ID: 19967317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Limousin P; Krack P; Pollak P; Benazzouz A; Ardouin C; Hoffmann D; Benabid AL
    N Engl J Med; 1998 Oct; 339(16):1105-11. PubMed ID: 9770557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
    Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
    Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
    Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
    Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.